Literature DB >> 12028827

Role of mitogen-activated protein kinase activation in the production of inflammatory mediators: differences between primary rat alveolar macrophages and macrophage cell lines.

K Murali Krishna Rao1, Terence Meighan, Linda Bowman.   

Abstract

Stimulation of macrophages has been shown to activate all three families of mitogen activated protein kinases (MAPKs). However, variable results are reported in the literature with respect to the particular kinases activated with any given stimulus. In this study, the role of activation of MAPKs was examined in the production of inflammatory mediators by measuring the phosphorylation of the kinases and their ability to phosphorylate specific substrates in rat primary alveolar macrophages, a rat alveolar macrophage cell line (NR8383), and two mouse monocytic cell lines (RAW 264.7 and J774A.1). In the three cell lines examined, all three families of MAPKs were activated upon stimulation with either lipopolysaccharide (LPS) or LPS plus interferon-gamma; in contrast, only ERK1/2 was activated in primary rat alveolar macrophages upon stimulation with LPS. Inhibition of ERK1/2 activation by the MEK inhibitor PD98059 abrogated nitric oxide and tumor necrosis factor-alpha (TNF-alpha) production in primary rat alveolar macrophages, but the p38 inhibitor SB203580 had no effect on the production of these two inflammatory mediators. These observations indicate that MAPK activation is cell specific and explain some of the conflicting results reported in the literature. These studies emphasize the need to exercise caution in extrapolating data from cell lines to primary cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028827     DOI: 10.1080/00984100290071027

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  7 in total

1.  Microarray analysis of Aeromonas hydrophila cytotoxic enterotoxin-treated murine primary macrophages.

Authors:  C L Galindo; A A Fadl; J Sha; A K Chopra
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.

Authors:  Yiguo Qiu; Pollob Kumar Shil; Ping Zhu; Hongxia Yang; Amrisha Verma; Bo Lei; Qiuhong Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

3.  Osteoinductive LIM mineralization protein-1 suppresses activation of NF-kappaB and selectively regulates MAPK pathways in pre-osteoclasts.

Authors:  Hui Liu; Maggie Bargouti; Susu Zughaier; Zhaomin Zheng; Yunshan Liu; Sreedhara Sangadala; Scott D Boden; Louisa Titus
Journal:  Bone       Date:  2009-11-18       Impact factor: 4.398

4.  Trimellitic anhydride-conjugated serum albumin activates rat alveolar macrophages in vitro.

Authors:  Dingena L Valstar; Marcel A Schijf; Erietta Stelekati; Frans P Nijkamp; Nanne Bloksma; Paul A J Henricks
Journal:  J Occup Med Toxicol       Date:  2006-06-23       Impact factor: 2.646

5.  SCRG1 suppresses LPS-induced CCL22 production through ERK1/2 activation in mouse macrophage Raw264.7 cells.

Authors:  Manabu Inoue; Junko Yamada; Emiko Aomatsu-Kikuchi; Kazuro Satoh; Hisatomo Kondo; Akira Ishisaki; Naoyuki Chosa
Journal:  Mol Med Rep       Date:  2017-04-20       Impact factor: 2.952

6.  Anti‑inflammatory activity of 3,5,6,7,3',4'‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells.

Authors:  Eun Suk Son; Jeong-Woong Park; Se-Hee Kim; Hye Ran Park; Woorijarang Han; O Chul Kwon; Jae Young Nam; Sung Hwan Jeong; Chang Soo Lee
Journal:  Mol Med Rep       Date:  2020-06-18       Impact factor: 2.952

7.  Particulate Matter-Induced Inflammation/Oxidative Stress in Macrophages: Fucosterol from Padina boryana as a Potent Protector, Activated via NF-κB/MAPK Pathways and Nrf2/HO-1 Involvement.

Authors:  Thilina U Jayawardena; K K Asanka Sanjeewa; Hyo-Geun Lee; D P Nagahawatta; Hye-Won Yang; Min-Cheol Kang; You-Jin Jeon
Journal:  Mar Drugs       Date:  2020-12-09       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.